Status:
COMPLETED
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
Lead Sponsor:
STEBA France
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
PHASE2
Brief Summary
This is a multi-centre, phase II, open-label, 12-month clinical trial for patients previously treated with WST09 (Tookad) who have positive prostate biopsies for cancer. The study aims at delivering ...
Detailed Description
Multi-centre, phase II, open-label, 12-month clinical trial for patients that previously received a vascular-targeted photodynamic treatment (VTP) with WST09 (Tookad) and still have histological findi...
Eligibility Criteria
Inclusion
- Patients previously treated with WST09-mediated VTP, with a positive biopsy of the prostate 6 months following treatment
- Disease confined to the prostate
- Life expectancy greater than 5 years
Exclusion
- Unwilling or unable to give informed consent
- Patients who have received another treatment for their prostate cancer since their previous WST09-mediated VTP
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00305929
Start Date
March 1 2006
End Date
December 1 2007
Last Update
June 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Prostate Centre Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9